Dynamic Biosensors

Dynamic Biosensors

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $40.6M

Overview

Dynamic Biosensors is a privately held German company providing innovative tools for the biophysical analysis of molecular interactions, primarily serving the drug discovery and life sciences research markets. The company's proprietary switchSENSE® and scIC technologies enable real-time, label-free kinetic measurements for molecule-molecule and molecule-cell interactions with high sensitivity. Its product portfolio includes the heliX® series of biosensor instruments, specialized chips, and software, positioning it as a key enabler for researchers tackling complex biological questions in areas like targeted protein degradation and immunotherapy. The company appears to be in a revenue-generating stage, selling instruments and consumables to academic and industrial research labs globally.

DiagnosticsProteomics

Technology Platform

switchSENSE® (DNA nano-lever technology for molecule-molecule interaction analysis) and single-cell Interaction Cytometry (scIC) for real-time, label-free kinetic measurements on live cells.

Funding History

4
Total raised:$40.6M
Series B$20M
Grant$2.1M
Series A$10M
Series A$8.5M

Opportunities

The growing complexity of novel drug modalities (PROTACs, multispecific antibodies, cell therapies) creates strong demand for advanced biophysical tools that can characterize intricate interactions and cell-surface kinetics.
Expansion into core facilities and large pharma, along with continued application development in high-impact fields like targeted protein degradation, presents significant growth potential.

Risk Factors

Facing intense competition from established biosensor companies and entrenched technologies.
Market adoption is critical and relies on convincing researchers to change workflows.
As a smaller private company, it may have limited resources for global scaling and R&D compared to larger competitors.

Competitive Landscape

Operates in the competitive biophysical analysis and label-free detection market, competing against giants like Cytiva (Biacore SPR), Sartorius (Octet BLI), and Nicoya Lifesciences. Its differentiation lies in the unique combination of kinetics, sizing, and live-cell interaction analysis, carving out a niche for complex, mechanistic studies that simpler affinity-based technologies cannot address.